TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11983635

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 32
Study: 10450007

Group type: EXPERIMENTAL
Intervention: Nuclear Matrix Protein 22 (NMP22) test
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: BTA stat test
Number of subjects: 140

Group type: COMPARATOR
Intervention: Cytology
Number of subjects: 140
Study: 7661124

Group type: EXPERIMENTAL
Intervention: Supplemented men (20 mg Fe/d)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Nonsupplemented men
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Supplemented women (20 mg Fe/d)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Nonsupplemented women
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both genders (regardless of iron intake)
Number of subjects: 36
Study: 2193113

Group type: EXPERIMENTAL
Intervention: Cefuroxime in bone cement
Number of subjects: 401

Group type: COMPARATOR
Intervention: Systemic cefuroxime
Number of subjects: 401
Study: 340333

Group type: EXPERIMENTAL
Intervention: Cimetidine, 300 mg four times daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30961956

Group type: EXPERIMENTAL
Intervention: Pneumonia diagnosis
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Clinico-radiological evidence of pneumonia
Number of subjects: 369

Group type: COMPARATOR
Intervention: COPD exacerbation or lower respiratory tract infection
Number of subjects: 369
Study: 30418075

Group type: EXPERIMENTAL
Intervention: Group Mindfulness-Based Cognitive-Behavioral Intervention (GMCI) for 8 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 70
Study: 27502948

Group type: EXPERIMENTAL
Intervention: NAVA
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional ventilation
Number of subjects: 60
Study: 24930169

Group type: EXPERIMENTAL
Intervention: Reliable automation
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Higher working memory capacity
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Increased communication rates of task-relevant information
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Word count of communications
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Automated decision aid
Number of subjects: 2
Study: 22173143

Group type: EXPERIMENTAL
Intervention: IPP (Infanrix, Pediacel, Pediacel)
Number of subjects: 253

Group type: COMPARATOR
Intervention: PPI (Pediacel, Pediacel, Infanrix)
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: IPP
Number of subjects: 253

Group type: COMPARATOR
Intervention: PPI
Number of subjects: 253
Study: 20444617

Group type: EXPERIMENTAL
Intervention: Left-sided unilateral cerebral perfusion
Number of subjects: 200

Group type: COMPARATOR
Intervention: Right-sided unilateral cerebral perfusion
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 200
Study: 17347539

Group type: EXPERIMENTAL
Intervention: Lingual split technique
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Surgical bur technique
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Simplified split bone technique
Number of subjects: 90

Group type: COMPARATOR
Intervention: All techniques
Number of subjects: 90
Study: 15914128

Group type: EXPERIMENTAL
Intervention: EE 20 microg/DRSP 3 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: EE 20 microg/DSG 150 microg
Number of subjects: 0
Study: 12365670

Group type: EXPERIMENTAL
Intervention: Bifocal glasses
Number of subjects: 46

Group type: COMPARATOR
Intervention: Single-vision glasses
Number of subjects: 46
Study: 10069630

Group type: EXPERIMENTAL
Intervention: Laparoscopic Nissen fundoplication (n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional open Nissen fundoplication (n = 10)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 20
Study: 8535309

Group type: EXPERIMENTAL
Intervention: rhG-CSF (n = 23) for 5 days
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: rhGM-CSF (n = 8) for 5 days
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: rhIL-3 (n = 6) for 10 days
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: rhIL-3, rhGM-CSF, rhG-CSF
Number of subjects: 37

Group type: COMPARATOR
Intervention: Primed expanded marrow grafts
Number of subjects: 37
Study: 2248428

Group type: EXPERIMENTAL
Intervention: Nicardipine hydrochloride
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 7235810

Group type: EXPERIMENTAL
Intervention: Sorbitol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no sorbitol)
Number of subjects: 0
Study: 31722295

Group type: EXPERIMENTAL
Intervention: Progressive resistance plus balance training for 24 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 29729256

Group type: EXPERIMENTAL
Intervention: Scheimpflug-based tomography (Pentacam; Oculus Inc)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Scanning-slit, Placido-based topography (Orbscan II; Bausch & Lomb)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 36
Study: 27395348

Group type: EXPERIMENTAL
Intervention: Exercise Training (ET)
Number of subjects: 2331

Group type: EXPERIMENTAL
Intervention: Atorvastatin, Simvastatin, Pravastatin
Number of subjects: 2331
Study: 25210881

Group type: EXPERIMENTAL
Intervention: Fulvestrant (FUL)
Number of subjects: 24
Study: 23162860

Group type: EXPERIMENTAL
Intervention: Daily multivitamin
Number of subjects: 14641

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14641
Study: 19921227

Group type: EXPERIMENTAL
Intervention: Operative treatment (cannulated screw fixation)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Conservative treatment (short arm cast)
Number of subjects: 94
Study: 18940395

Group type: EXPERIMENTAL
Intervention: Plasma bFGF immunoreactivity (bFGF‐IR) measured in pg/mL
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Log plasma bFGF
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Multiple regression analysis
Number of subjects: 281
Study: 16187480

Group type: EXPERIMENTAL
Intervention: Standard esophagectomy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Chemoradiotherapy
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 80
Study: 12592177

Group type: EXPERIMENTAL
Intervention: Expectant management
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgical evacuation
Number of subjects: 0
Study: 10658042

Group type: EXPERIMENTAL
Intervention: Acetazolamide (Acz, 10 mg/kg body wt iv)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control (Con)
Number of subjects: 7
Study: 8856425

Group type: EXPERIMENTAL
Intervention: Counselling visits by the Child Health Clinic nurse (6 weekly sessions)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Routine primary care (control group)
Number of subjects: 41
Study: 1310385

Group type: EXPERIMENTAL
Intervention: Intravenous immune globulin and oral acyclovir prophylaxis
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no prophylaxis)
Number of subjects: 100
Study: 6436890

Group type: EXPERIMENTAL
Intervention: Nicotine 1.5 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Scopolamine 1.2 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Combined doses of scopolamine 1.2 mg and nicotine 1.5 mg
Number of subjects: 18
Study: 30636006

Group type: EXPERIMENTAL
Intervention: CBCC resource pack + workshop
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: CBCC resource pack only
Number of subjects: 345

Group type: COMPARATOR
Intervention: Nutrition booklet
Number of subjects: 345

Group type: COMPARATOR
Intervention: No interventions (waitlist control)
Number of subjects: 345
Study: 28761118

Group type: EXPERIMENTAL
Intervention: Bortezomib (BTZ) before and after high-dose melphalan and autologous stem cell transplantation (HDM, PAD arm)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Classical cytotoxic agents prior and thalidomide after HDM (VAD arm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bortezomib (BTZ) before and after high-dose melphalan and autologous stem cell transplantation (PAD arm)
Number of subjects: 0
Study: 24627234

Group type: EXPERIMENTAL
Intervention: Brief interview prior to inpatient discharge plus usual care
Number of subjects: 195

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 195
Study: 25315887

Group type: EXPERIMENTAL
Intervention: Real-time ultrasound elastography
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (healthy controls)
Number of subjects: 31
Study: 22790470

Group type: EXPERIMENTAL
Intervention: Weekly doses of levothyroxine (LT4)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Daily doses of levothyroxine (LT4)
Number of subjects: 14
Study: 20182915

Group type: EXPERIMENTAL
Intervention: Qualitative thematic analysis of patients' perceptions and experiences regarding their bipolar disorder diagnosis.
Number of subjects: 0
Study: 17586303

Group type: EXPERIMENTAL
Intervention: Valsartan (320 mg once daily)
Number of subjects: 384

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 384
Study: 15883561

Group type: EXPERIMENTAL
Intervention: Calcium citrate malate
Number of subjects: 25

Group type: COMPARATOR
Intervention: Tricalcium phosphate/calcium lactate
Number of subjects: 25
Study: 12471537

Group type: EXPERIMENTAL
Intervention: 40 mg omeprazole daily for eradication of the metaplastic epithelium
Number of subjects: 39

Group type: COMPARATOR
Intervention: 20 mg omeprazole daily for long-term acid suppression
Number of subjects: 39

Group type: COMPARATOR
Intervention: 40 mg omeprazole daily for long-term acid suppression
Number of subjects: 39
Study: 9506313

Group type: EXPERIMENTAL
Intervention: Techno-music
Number of subjects: 16

Group type: COMPARATOR
Intervention: Classical music
Number of subjects: 16
Study: 7596261

Group type: EXPERIMENTAL
Intervention: Patients not being treated with Sinemet (levodopa/carbidopa)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Elderly subset of patients (51-70 years old)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Age-matched control group
Number of subjects: 151
Study: 2788605

Group type: EXPERIMENTAL
Intervention: Semirigid orthotic device (Langer military stress orthotic)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal foot with low arch
Number of subjects: 0
Study: 963349

Group type: EXPERIMENTAL
Intervention: Immediate appointments
Number of subjects: 234

Group type: COMPARATOR
Intervention: Delayed appointments
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Initial attenders
Number of subjects: 234
Study: 31449914

Group type: EXPERIMENTAL
Intervention: Nemolizumab 30 mg
Number of subjects: 226
Study: 31491181

Group type: EXPERIMENTAL
Intervention: Randomized benchmarking of quantum gates
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Benchmarking tensor powers of T gates
Number of subjects: 0
Study: 28627401

Group type: EXPERIMENTAL
Intervention: Educational nutrition messaging (EM), n = 16
Number of subjects: 33

Group type: COMPARATOR
Intervention: No messaging (NM), n = 17
Number of subjects: 33
Study: 25644291

Group type: EXPERIMENTAL
Intervention: Sacral nerve stimulation (SNS)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Percutaneous tibial nerve stimulation (PTNS)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Chronic implanted stimulation (SNS)
Number of subjects: 40
Study: 23234631

Group type: EXPERIMENTAL
Intervention: Toremifene (80 mg by mouth daily)
Number of subjects: 646

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 646

Group type: EXPERIMENTAL
Intervention: Toremifene
Number of subjects: 646
Study: 16304701

Group type: EXPERIMENTAL
Intervention: GSM signals exposure
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: CW signals exposure
Number of subjects: 168

Group type: COMPARATOR
Intervention: Sham signals exposure
Number of subjects: 168
Study: 12723054

Group type: EXPERIMENTAL
Intervention: Oscillometry combined with the recursive weighted regression algorithm (RWRA)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Traditional curve fitting algorithm (TCFA)
Number of subjects: 47
Study: 10798755

Group type: EXPERIMENTAL
Intervention: Enteral supplementation (calorie‐dense enteral feed taken daily until transplantation)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (no enteral supplementation)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Both groups (supplemented and control)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Preoperative grip strength <85% of normal values
Number of subjects: 82
Study: 8973689

Group type: EXPERIMENTAL
Intervention: Combination of low-dose BCG (60 mg) and IFN alpha 2b (10, 30, 60, or 100 x 10(6) IU) given weekly for 6 weeks
Number of subjects: 12
Study: 1358563

Group type: EXPERIMENTAL
Intervention: Oxatomide (60 mg/day in a single evening administration)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Disodium chromoglycate (DSCG, 2000 mg/day)
Number of subjects: 20
Study: 3881631

Group type: EXPERIMENTAL
Intervention: Carpentier's annuloplasty
Number of subjects: 159

Group type: COMPARATOR
Intervention: De Vega's annuloplasty
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Carpentier's annuloplasty (excluding patients with high total pulmonary resistances or organic tricuspid damage)
Number of subjects: 159

Group type: COMPARATOR
Intervention: De Vega's annuloplasty (excluding patients with high total pulmonary resistances or organic tricuspid damage)
Number of subjects: 159
Study: 29254408

Group type: EXPERIMENTAL
Intervention: 6-month health multidimensional intervention
Number of subjects: 337
Study: 28720234

Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 186

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 186
Study: 26510621

Group type: EXPERIMENTAL
Intervention: Tourniquet group
Number of subjects: 70

Group type: COMPARATOR
Intervention: Non‐tourniquet group
Number of subjects: 70
Study: 23569007

Group type: EXPERIMENTAL
Intervention: Scheduled Gradual Reduction (SGR)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Support messages only
Number of subjects: 31
Study: 19651449

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20mg/day and amlodipine 10mg/day
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Amlodipine 10mg/day
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20mg/day
Number of subjects: 42

Group type: COMPARATOR
Intervention: Atorvastatin 20mg/day and placebo
Number of subjects: 42

Group type: COMPARATOR
Intervention: Amlodipine 10mg/day and placebo
Number of subjects: 42
Study: 19673958

Group type: EXPERIMENTAL
Intervention: Tissue-engineered bone (test site - Oral Bone, BioTissue, Freiburg, Germany)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Calcium phosphate (control site - Biocoral, Novaxa Spa, Milan, Italy)
Number of subjects: 5
Study: 17905651

Group type: EXPERIMENTAL
Intervention: Caffeine (250 mg)
Number of subjects: 0
Study: 15030838

Group type: EXPERIMENTAL
Intervention: Intravenous midazolam (0.015 mg/kg body weight) 15 minutes before surgery
Number of subjects: 100

Group type: COMPARATOR
Intervention: No sedation (Control group)
Number of subjects: 100
Study: 11859658

Group type: EXPERIMENTAL
Intervention: 400 mg of norfloxacine
Number of subjects: 126

Group type: COMPARATOR
Intervention: Nothing (control group)
Number of subjects: 126
Study: 9620520

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cuffed Tracheal Tube (TT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Comparison of LMA and TT at 10 min
Number of subjects: 40

Group type: COMPARATOR
Intervention: Comparison of LMA and TT at 60 min
Number of subjects: 40
Study: 8058691

Group type: EXPERIMENTAL
Intervention: Nursing model intervention
Number of subjects: 24
Study: 2921817

Group type: EXPERIMENTAL
Intervention: metoclopramide and dexamethasone
Number of subjects: 42

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 42
Study: 31930360

Group type: EXPERIMENTAL
Intervention: Behavioral therapy
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Drug therapy
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Combined therapy
Number of subjects: 204
Study: 30994775

Group type: EXPERIMENTAL
Intervention: In‐Ovation®R
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: SmartClipTM
Number of subjects: 20

Group type: COMPARATOR
Intervention: GeminiTM
Number of subjects: 20
Study: 28342534

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102

Group type: COMPARATOR
Intervention: Etanercept 50mg twice weekly
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Ixekizumab 160mg starting dose followed by 80mg Q2W
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Ixekizumab 160mg starting dose followed by 80mg Q4W
Number of subjects: 102
Study: 27163422

Group type: EXPERIMENTAL
Intervention: GCR + IMT (inspiratory muscle training program associated with combined training)
Number of subjects: 24

Group type: COMPARATOR
Intervention: GCR (combined training with respiratory exercises)
Number of subjects: 24
Study: 23405024

Group type: EXPERIMENTAL
Intervention: Reflexology
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham Reflexology
Number of subjects: 20
Study: 22051355

Group type: EXPERIMENTAL
Intervention: Experimental condition (n=41)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control condition (n=44)
Number of subjects: 85
Study: 19673717

Group type: EXPERIMENTAL
Intervention: Routine (nontargeted) opt-out rapid HIV screening
Number of subjects: 0

Group type: COMPARATOR
Intervention: Physician-directed diagnostic rapid HIV testing
Number of subjects: 0
Study: 16378695

Group type: EXPERIMENTAL
Intervention: l-5-Hydroxytryptophan (200 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Citalopram (20 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Citalopram (20 mg) and l-5-Hydroxytryptophan (200 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Citalopram (40 mg)
Number of subjects: 0
Study: 15623713

Group type: EXPERIMENTAL
Intervention: High-frequency (5 Hz) repetitive transcranial magnetic stimulation (rTMS) applied over the right dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-frequency (5 Hz) repetitive transcranial magnetic stimulation (rTMS) applied over the supplementary motor area
Number of subjects: 0
Study: 10907353

Group type: EXPERIMENTAL
Intervention: Prednisone 5 to 7.5 mg per day
Number of subjects: 36

Group type: COMPARATOR
Intervention: Non-steroid control group
Number of subjects: 36
Study: 9049578

Group type: EXPERIMENTAL
Intervention: Nebivolol 5 mg once daily for 7 days
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nebivolol 5 mg once daily for 1 day
Number of subjects: 12

Group type: COMPARATOR
Intervention: Atenolol 25 mg once daily for 7 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Atenolol 100 mg once daily for 7 days
Number of subjects: 12
Study: 8244259

Group type: EXPERIMENTAL
Intervention: 3 MU recombinant interferon-alpha 2b
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 1 MU recombinant interferon-alpha 2b
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 3748634

Group type: EXPERIMENTAL
Intervention: Tonic stimuli (5-minute projected white triangle or circle) with phasic stimuli (5-second red or green square) paired with shock.
Number of subjects: 48

Group type: COMPARATOR
Intervention: Tonic stimuli (5-minute projected white triangle or circle) with phasic stimuli (5-second red or green square) alone.
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Phasic stimuli controlled by different phasic stimuli.
Number of subjects: 48
Study: 29509641

Group type: EXPERIMENTAL
Intervention: 2 mg·kg caffeine
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: 4 mg·kg caffeine
Number of subjects: 101

Group type: COMPARATOR
Intervention: 0 mg·kg caffeine (placebo)
Number of subjects: 101
Study: 27448485

Group type: EXPERIMENTAL
Intervention: Rotigotine
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 24828838

Group type: EXPERIMENTAL
Intervention: Cognitive restructuring skill acquisition during group CBT
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Standardised CBT
Number of subjects: 44
Study: 20593332

Group type: EXPERIMENTAL
Intervention: Water immersion
Number of subjects: 229

Group type: COMPARATOR
Intervention: Standard air insufflation
Number of subjects: 229
Study: 18410471

Group type: EXPERIMENTAL
Intervention: Fluvastatin (20 to 320 mg/day)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Fluvastatin (80 mg/day or less)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Fluvastatin
Number of subjects: 31
Study: 15729576

Group type: EXPERIMENTAL
Intervention: Insulin detemir
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: High-dose insulin detemir
Number of subjects: 7

Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 7
Study: 11839710

Group type: EXPERIMENTAL
Intervention: Oats diet (allowed to eat oats freely in conjunction with a gluten free diet)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Conventional gluten free diet (control group)
Number of subjects: 92
Study: 10379115

Group type: EXPERIMENTAL
Intervention: Demineralized freeze‐dried bone allograft (DFDBA) with expanded polytetrafluoroethylene (e‐PTFE) membrane
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (untreated sites)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Demineralized freeze‐dried bone allograft (DFDBA)
Number of subjects: 8
Study: 8818852

Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg/day orally once daily for 3 days
Number of subjects: 204

Group type: COMPARATOR
Intervention: Roxithromycin 150 mg orally twice daily for 10 days
Number of subjects: 204
Study: 1882897

Group type: EXPERIMENTAL
Intervention: Sucralfate (Sc) 6 g/day
Number of subjects: 125

Group type: COMPARATOR
Intervention: Ranitidine (Rn) 150 mg
Number of subjects: 125
Study: 7078714

Group type: EXPERIMENTAL
Intervention: High dose diazepam (150-200 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: High dose diazepam (150-200 mg/day) with naloxone (30 mg i.v.)
Number of subjects: 0
Study: 31865423

Group type: EXPERIMENTAL
Intervention: Caloric restriction with fish oil (CRF)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Caloric restriction (CR)
Number of subjects: 21
Study: 30998048

Group type: EXPERIMENTAL
Intervention: Positive Affect Treatment (PAT)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Negative Affect Treatment (NAT)
Number of subjects: 96